Patient Guide: A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 5 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06008353
Status: ACTIVE_NOT_RECRUITING
Condition: Extensive-stage Small-cell Lung Cancer
Phase: Research Study

Find a Study Location Near You

This study is available at 5 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Salvador, Bahia
  • Recife, Pernambuco
  • Rio De Janeiro,
  • • And 2 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily